WHO-EORTC classification for cutaneous lymphomas

R Willemze, ES Jaffe, G Burg, L Cerroni, E Berti… - Blood, 2005 - ashpublications.org
Primary cutaneous lymphomas are currently classified by the European Organization for
Research and Treatment of Cancer (EORTC) classification or the World Health Organization …

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer

M Arbyn, G Ronco, A Anttila, CJLM Meijer, M Poljak… - Vaccine, 2012 - Elsevier
More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

J Cuzick, M Arbyn, R Sankaranarayanan, V Tsu… - Vaccine, 2008 - Elsevier
Screening for cervical cancer precursors by cytology has been very successful in countries
where adequate resources exist to ensure high quality and good coverage of the population …

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

JMM Walboomers, MV Jacobs… - The Journal of …, 1999 - Wiley Online Library
A recent report that 93 per cent of invasive cervical cancers worldwide contain human
papillomavirus (HPV) may be an underestimate, due to sample inadequacy or integration …

[HTML][HTML] Epidemiologic classification of human papillomavirus types associated with cervical cancer

N Muñoz, FX Bosch, S De Sanjosé… - New England journal …, 2003 - Mass Medical Soc
Background Infection with human papilloma virus (HPV) is the main cause of cervical
cancer, but the risk associated with the various HPV types has not been adequately …

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

S de Sanjose, WGV Quint, L Alemany… - The lancet …, 2010 - thelancet.com
Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in
invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We …

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

G Ronco, J Dillner, KM Elfström, S Tunesi, PJF Snijders… - The lancet, 2014 - thelancet.com
Background In four randomised trials, human papillomavirus (HPV)-based screening for
cervical cancer was compared with cytology-based cervical screening, and precursors of …

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

N Muñoz, FX Bosch, X Castellsagué… - … journal of cancer, 2004 - Wiley Online Library
At least 15 types of HPV have been associated with cervical cancer, but current HPV
vaccines confer only type‐specific immunity. To determine geographic variations in the HPV …

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study

R Herrero, X Castellsagué, M Pawlita… - Journal of the …, 2003 - academic.oup.com
Abstract Background: Human papillomavirus (HPV), the causal agent of cervical cancer,
appears to be involved in the etiology of cancer of the oral cavity and oropharynx. To …

The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR

AM de Roda Husman… - Journal of general …, 1995 - microbiologyresearch.org
Sequence analysis of human papillomavirus (HPV) general primer GP5/6 mediated PCR
products revealed the presence of short highly conserved sequences adjacent to the 3 …